France Prostate Cancer Diagnostic and Therapeutic Market Value Projected to Expand by 2025
France prostate cancer market is forecast to grow at a CAGR of 11.5% during the forecast period. The country is among the most susceptible to the prostate cancer in Europe. As per the World Health Organization, around 25% of the overall cancer cases are of prostate cancer, which is around 65,000 in 2018. The 5-year prevalence in the country due to prostate cancer is around 228,000 in 2018. In the country, obesity is one of the major factors of prostate cancer. The country has a high consumption of alcohol, smoking, a high level of animal fat consumption, serum total cholesterol and high-density lipoprotein cholesterol concentrations. Due to this, individuals are more prone to becoming obese increasing their chances of being affected with prostate cancer.
(Get 25% Discount on Buying this Report)
To Request a Sample of our Report on France
Prostate Cancer Diagnostic and Therapeutic Market: https://www.omrglobal.com/request-sample/france-prostate-cancer-diagnostic-therapeutic-market
Government initiatives for prostate
cancer management are one of the factors augmenting the demand for prostate
cancer diagnostic and therapeutic. France government has been actively
supporting the healthcare system with most of the chronic diseases, 100%
covered by French statuary health insurance. The healthcare system in France is
one of the universal healthcare majorly financed by government national health
insurance. The state covers the healthcare costs of residents not eligible for
Statuary Health Insurance (SHI). The state also covers illegal immigrants who
have applied for residency, as well as residents from the EU. Non-EU visitors
are covered for emergency services only.
A
full Report of France Prostate Cancer Diagnostic and Therapeutic Market is
Available @ https://www.omrglobal.com/industry-reports/france-prostate-cancer-diagnostic-therapeutic-market
France Prostate Cancer Diagnostic and Therapeutic Market Segmentation
By Diagnostic Techniques
·
Prostate-Specific Antigen Test (PSA)
·
Digital Rectal Examination
·
Prostate Biopsy
·
Imaging Techniques
By Therapeutics
·
Hormonal Therapy
·
Chemotherapy
·
Immunotherapy
·
Radiation Therapy
·
Targeted Therapy
·
Surgery
Company Profiles
·
Abbott Laboratories
·
AbbVie Products, LLC
·
Amgen Inc.
·
AstraZeneca PLC
·
Bayer AG
·
Bristol-Myers Squibb Co.
·
Ferring Pharmaceuticals Inc.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Pfizer Inc.
·
Siemens Healthcare AG
·
Ipsen Group
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment